MoonLake Immunotherapeutics (MLTX) Interest Coverage Ratio (2022 - 2026)

MoonLake Immunotherapeutics' Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 30.86 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 98.83% year-over-year to 30.86; the TTM figure through Mar 2026 stood at 28.15 (up 99.7% YoY), while the FY2025 annual figure was 33.78, changed N/A from the prior year.
• Interest Coverage Ratio was 30.86 for Q1 2026 at MoonLake Immunotherapeutics, up from 32.71 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 22.34 in Q3 2025 to a low of 24265.32 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 4503.18 across 3 years, with a median of 31.78 in 2025.
• Biggest YoY gain for Interest Coverage Ratio was 98.83% in 2026; the steepest drop was 98.83% in 2026.
• A 3-year view of Interest Coverage Ratio shows it stood at 24265.32 in 2022, then surged by 99.87% to 32.71 in 2025, then advanced by 5.64% to 30.86 in 2026.
• The last three Interest Coverage Ratio figures came in at 30.86 (Q1 2026), 32.71 (Q4 2025), and 22.34 (Q3 2025), per Business Quant data.